Tag: psychiatric
-
Partnership to Discover Mental Health Peptides in Milk
A collaboration between biotechnology and dairy products businesses seeks to identify peptides in milk to form into dietary supplements for people with mood disorders.
-
Biotech, Univ. Labs Test Psychoactive Drug as PTSD Therapy
A developer of treatments with psychedelic compounds for brain disorders is partnering with a lab at Yale University to assess methylone as a PTSD therapy.
-
Autoimmune Neuro Disease Start-Up Raises $58M
A new company developing treatments for neurological and psychiatric diseases from aberrant immune system activity is raising $58 million in seed funds.
-
Health App Shown to Improve Asthma, Depression Outcomes
Findings from two clinical trials show a digital health mobile app helps improve outcomes and manage the conditions for people with depression and asthma.
-
FDA Issues Guidance for Opioid Therapy Device Trials
The U.S. Food and Drug Administration issued new regulatory guidance for clinical trials of medical devices designed to prevent or treat opioid use disorder.
-
NIH Funds Depression Game Therapy Clinical Trial
A treatment for depression designed as a game for patients will be assessed in a clinical trial conducted by a university psychology lab and funded by National Institutes of Health.
-
Drug Maker, Univ. Lab Partner on Neuropeptide Anxiety Trial
A biopharmaceutical company and university neuroscience lab are collaborating on a clinical trial testing a peptide nasal spray treatment for social anxiety disorder.
-
Neuro Biomarkers, Home EEG Assessed in Upcoming Trial
A digital biomarkers company and developer of neuroscience analytics are collaborating on a study of EEG measurements and algorithms with a wearable device at home.
-
Low-Dose Oral Film Reduces Mental Disorder Agitation
Interim results from a clinical trial show a drug given as a dissolvable oral film in a lower dose reduces agitation in people with bipolar disorder and schizophrenia.
-
Safer Forms of Psilocybin Assessed in Preclinical Study
A biotechnology company says it identified engineered precursors of a psychedelic compound that in lab animals produce safe and intended therapeutic effects.